Semaglutide boosts kidney outcomes with obesity + cardiovascular disease
May 28, 2024
At the prespecified 104-week time point, semaglutide was associated with a lesser decline in eGFR than placebo.
Statins reduce CVD risk in adults aged 75 to 85 and 85 years and older
May 28, 2024
A risk reduction was seen for overall cardiovascular disease incidence for initiating statin therapy in both intention-to-treat and per-protocol analyses.
Plant-based diets tied to long-term health benefits
May 15, 2024
The benefits include a better cardiometabolic risk profile as well as lower mortality.
AI-informed health app aids diabetes outcomes
May 15, 2024
The app gives tailored nutrition and health recommendations, which are linked to decreases in HbA1c and heart disease risk.
Four in 10 adults with diabetes report taking a GLP-1 receptor agonist
May 14, 2024
Even with healthcare insurance, users report difficulty paying for the medication.
More medical lab tests will soon face federal scrutiny, FDA says
Apr 29, 2024
Laboratory tests used by millions of Americans are soon to be classified as medical devices, and as such be regulated by the US Food and Drug Administration, the agency announced Monday.
AI may be useful in polypharmacy management
Apr 24, 2024
ChatGPT deprescribing decisions varied along activities of daily living status, cardiovascular disease history, and medication type
AI could play role in preventing prescribing of unnecessary drugs in older adults
By
Kristen Fischer
Apr 22, 2024
A new study finds that artificial intelligence could encourage doctors to stop prescribing drugs that aren’t necessary.
Salt substitution may reduce all-cause, cardiovascular mortality
Apr 08, 2024
A slight reduction was seen in major cardiovascular events; very low certainty of serious adverse events was reported.